Andre A Konski, M.D.

faculty photo
Professor of Clinical Radiation Oncology
Department: Radiation Oncology

Contact information
Chester County Hospital
701 East Marshall St.
West Chester, PA 19380
Office: 610 431 5530
Lab: 610 431 5530
BA (Biology)
Saint Michael's College, Winooski, VT, 1980.
New York Medical College, Valhalla, N.Y., 1984.
University of Toledo, Toledo, Ohio, 1995.
MA (Economics)
University of Toledo, Toledo, Ohio, 1998.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, Stea B, Yoon H, Li J, Laack NN, Kruser TJ, Chmura SJ, Shi W, Deshmukh S, Mehta MP, Kachnic LA: Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol 38(10): 1019, April 2020.

Russo S, Anker CJ, Abdel-Wahab M, Azad N, Das P, Dragovic J, Goodman KA, Herman JM, Jones W 3rd, Kennedy T, Konski A, Kumar R, Lee P, Patel NM, Sharma N, Small W, Suh WW, Jabbour SK: Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer. Int J Radiat Oncol Biol Phy 105(5): 977, December 2019.

Rivin Del Campo E, Matzinger O, Haustermans K, Peiffert D, Glynne-Jones R, Winter KA, Konski AA, Ajani JA, Bosset JF, Hannoun-Levi JM, Puyraveau M, Chakravarthy AB, Meadows H, Northover J, Collette L, Christiaens M, Maingon P.: Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC). Eur J Cancer 121: 130, November 2019.

Xiao C: Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities. Adv Radiat Oncol 3(3): 405, June 2018.

Konski A: An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-efficacy of Concurrent vs Sequential Chemoradiotherapy. J Radiat Oncol 7(2): 195, June 2018.

Konski A: Cost effectiveness of prostate cancer radiotherapy. Transl Androl Urol 7(3): 371, june 2018.

Bajaj A, Harmon G, Weaver J, Martin B, Mysz M, Surucu M, Roeske JC, Konski AA, Small W Jr, Harkenrider MM: A Medicare cost analysis of MRI- versus CT-based high-dose-rate brachytherapy of the cervix: Can MRI-based planning be less costly? Brachytherapy. 17(2): 326-333, Mar-Apr 2018.

Amin NP, Nalichowski A, Campbell S, Hyder J, Spink R, Konski AA, Dominello M.: Helical Therapy is Safe for Lung Stereotactic Body Radiation Therapy Despite Limitations in Achieving Sharp Dose Gradients. Technol Cancer Res Treat. 16(6): 1173-1178, Dec 2017.

Suntharalingam M, Winter K, Ilson D, Dicker AP, Kachnic L, Konski A, Chakravarthy AB, Anker CJ, Thakrar H, Horiba N, Dubey A, Greenberger JS, Raben A, Giguere J, Roof K, Videtic G, Pollock J, Safran H, Crane CH.: Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial. JAMA Oncology 3(11): 1520-1528, Novermber 2017.

A.A. Konski: Letting Patients Decide How to Receive Their Imaging Results; A Good Idea or a Dangerous Practice? Part 2: Counterpoint: Patients Should Not Have Unchaperoned Access to Radiology Reports. J Am Coll Radiol 14(10): 1351-1352, october 2017.

back to top
Last updated: 10/07/2020
The Trustees of the University of Pennsylvania